230 related articles for article (PubMed ID: 29494553)
21. Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells.
Gambera S; Abarrategi A; Rodríguez-Milla MA; Mulero F; Menéndez ST; Rodriguez R; Navarro S; García-Castro J
Stem Cells; 2018 Oct; 36(10):1487-1500. PubMed ID: 30001480
[TBL] [Abstract][Full Text] [Related]
22. Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Cell Commun Signal; 2018 Apr; 16(1):13. PubMed ID: 29625612
[TBL] [Abstract][Full Text] [Related]
23. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
24. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
25. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
[TBL] [Abstract][Full Text] [Related]
27. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p.
Han Q; Yang J; Yang H; Li C; Li J; Cao Y
Cell Cycle; 2020 May; 19(10):1172-1185. PubMed ID: 32286148
[No Abstract] [Full Text] [Related]
28. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
[TBL] [Abstract][Full Text] [Related]
29. Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.
Ying M; Liu G; Shimada H; Ding W; May WA; He Q; Adams GB; Wu L
Oncogene; 2013 Sep; 32(36):4252-63. PubMed ID: 23045288
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
[TBL] [Abstract][Full Text] [Related]
31. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.
Zhang H; Wu H; Zheng J; Yu P; Xu L; Jiang P; Gao J; Wang H; Zhang Y
Stem Cells; 2013 Mar; 31(3):433-46. PubMed ID: 23225703
[TBL] [Abstract][Full Text] [Related]
33. In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients.
Lucarelli E; Bellotti C; Mantelli M; Avanzini MA; Maccario R; Novara F; Arrigo G; Zuffardi O; Zuntini M; Pandolfi M; Sangiorgi L; Lisini D; Donati D; Duchi S
J Transl Med; 2014 Apr; 12():95. PubMed ID: 24716831
[TBL] [Abstract][Full Text] [Related]
34. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner.
Fernández L; Valentín J; Zalacain M; Leung W; Patiño-García A; Pérez-Martínez A
Cancer Lett; 2015 Nov; 368(1):54-63. PubMed ID: 26276724
[TBL] [Abstract][Full Text] [Related]
35. Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.
Bonuccelli G; Avnet S; Grisendi G; Salerno M; Granchi D; Dominici M; Kusuzaki K; Baldini N
Oncotarget; 2014 Sep; 5(17):7575-88. PubMed ID: 25277190
[TBL] [Abstract][Full Text] [Related]
36. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
37. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
[TBL] [Abstract][Full Text] [Related]
38. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
39. Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.
Fioramonti M; Fausti V; Pantano F; Iuliani M; Ribelli G; Lotti F; Pignochino Y; Grignani G; Santini D; Tonini G; Vincenzi B
Sci Rep; 2018 Mar; 8(1):4177. PubMed ID: 29520051
[TBL] [Abstract][Full Text] [Related]
40. Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.
Wang Y; Chu Y; Yue B; Ma X; Zhang G; Xiang H; Liu Y; Wang T; Wu X; Chen B
Oncotarget; 2017 Apr; 8(14):23803-23816. PubMed ID: 28423603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
